These Nonprofits Just Shelled Out $5.2 Million to Fund An Experimental Parkinson’s Drug
According to a story from PR Newswire, the biotech company Mission Therapeutics was just awarded $5.2 million in funding to support MTX325, the company's investigational Parkinson's disease therapy. Intended to…